FDA rule may protect firms from disclosure lawsuits

08/22/2008 | Bloomberg

The FDA issued a rule that limits revisions made to product warnings by drug and medical-device makers. The rule clarifies long-standing FDA policy and allows companies to add information to labels before a complete FDA review in particular cases. An agency official said the move would clarify and "provide additional confidence to patients and doctors that information on medical-product labels has a sensible scientific basis."

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Director, Site Quality Management
CareFusion
Palm Springs, CA